BUSINESS● LOWAug 3 · Aug 3, 2026, 6:32 PM
TG Therapeutics down 11% following Q2 bottom line miss
Seeking Alpha Tech
TG Therapeutics' stock has fallen by 11% after the company missed its second-quarter bottom line expectations. This indicates a negative market response to the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoIBM Q3 Preview: Can software and AI rebuild confidence after a rough Q2?Seeking Alpha TechBUSINESS20m agoJapan resumes imports of Ukrainian poultry after five-year restrictionsUkrinform [en]